Immunotherapy is the form of treatment that redirects the immune system toward a pathogen or disease. In many cases, ...
University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...
During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...
AZoLifeSciences on MSN5h
Dysfunctional Memory B Cells Identified as Key Cancer Therapy TargetUniversity of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...
Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to I™), today announced a ...
The addition of epcoritamab-bysp to standard chemotherapy significantly improved response and survival for patients with ...
CAR T-cell therapy showed efficacy in relapsed large B-cell lymphoma across age groups, including patients 70 and 80 years or older.
Despite research showing the benefits of circulating tumor DNA as an indicator of disease remission in B-cell lymphoma, ...
Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...
The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback